Palma DM, Hinojosa R, Vales HLO

Idioma: Español
Referencias bibliográficas: 23
Paginas: 166-170
Archivo PDF: 45.31 Kb.

RESUMEN

Los tumores del ángulo pontocerebeloso constituyen una de las principales neoplasmas intracraneales. Su diagnóstico temprano es ideal pues cuando es tardío son de gran tamaño y causan daño a las estructuras vecinas, a falta de información hace que sean referidas tardiamente a un servicio adecuado. En nuestro servicio recibimos pacientes con tumores de gran tamaño con audición pérdida 50% y afección de otros pares craneales. El 39% acudió de 1 a 5 años de la aparición de los síntomas. Es importante que la información se difunda para que los pacientes acudan en forma temprana a un tratamiento adecuado.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Propp Jennifer M. Descriptive epidemiology of vestibular schwannomas, Neuro-Oncology 2006:8:1-11.

2. Canalis Rinaldo, Lambert Paul. The ear: comprehensive otology. Lippincott Williams & Wilkins, Philadelphia 2000.

3. Nedzelski JM. Cerebellopontine angle tumors: bilateral flocculus compression as causse of associated oculomotor anormalities. Laryngoscope 1983;93: 1251-60.

4. Croxson GR, Moffat DA, Baguley D. Bruns’ birirectional nystagmus in cerebellopontine angle tumors. Clin Otolaryngol 1988;13:153-7.

5. Beck HJ, Beatty CW, Hamer SG. Acoustic neuromas with normal pure tone hearing levels. Otolaryngol Head Neck Surg 1986;94:96-103.

6. Barrs DM, Brackmann DE. Changing concepts of acoustic neuroma diagnosis. Arch Otolaryngol 1985;111: 17-21.

7. Som P, Curtin H. Head and neck imaging. Mosby 4a ed 2003.

8. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg 1995;113(3).

9. Battaglia Alex, Mastrodimos Bill, Cueva Roberto. Comparision of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol 2006; 27(5):705-12.

10. Wayne Harsha, Douglas Backhous. Counseling patients on surgical options for treating acoustic neuromas. Otolaryngol Clin Am 2005;38:643-52.

11. Slattery W, Brackmann D, Owens R, Friedman R. Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 2000; 21(3):417-24.

12. Brackmann D, Owens R, Friedman R. Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 2000; 21 (3):417-24.

13. Satar B, Jackler R, Oghalai J. Risk-benefit analysis of using the middle fossa approach for acoustic neuromas with > 10 mm cerebellopontine angle component. Laryngoscope 2002; 112: 1500-6.

14. Lassaletta L, Fontes L, Melcon E. Hearing preservation with the retrosigmoid approach for vestibular schwannoma: myth or reality? Otolaryngol Head Neck Surg 2003; 129 (4):397-401.

15. Mangham C. Retrosigmoid versus middle fossa surgery for small vestibular schwannoma. Laryngoscope 2004;114:1455-61.

16. Colletti V, Fiorsio F. Middle fossa versus retrosigmoid-transmeatal approach in vestibular schwannoma surgery: a prospective study. Otol Neurotol 2003; 24:927-34.

17. Arriaga M, Chen D. Facial function in hearing preservation acoustic neuroma surgery. Arch Otolaryngol Head Neck Surg 2001; 127:543-6.

18. Sanna M, Khrars T. Hearing preservation surgery in vestibular schwannoma:the hidden truth. Ann Otol Rhinol Laryngol 2004; 113: 156-63.

19. Marnikoglu B, Esquivel C, Wiet R. Comparision of facial nerve function results after translabrinthine and retrosigmoid approach in medium-sized tumors. Arch Otolaryngol Head Neck Surg 2003; 129:429-31.

20. Magnan J, Barbieri M. Retrosigmoid approach for small and medium-sized acoustic neuromas. Otol Neurotol 2002; 23:141-5.

21. Herwadker Amit. Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentation, Otol Neurotol 2005; 26:86-92.

22. 22, Hasegawa Toshinori. Stereotactic radiosurgery for vestibular schwannomas: analysis of 317 patients followed more than 5 years. Neurosurgery 2005; 57:257-65.

23. Pollock Bruce. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery 2006; 58:241-8.